Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey.
Emily K YeungA K BelloAdeera LevinMeaghan LunneyMohamed A OsmanFeng YeGloria AshuntantangEzequiel Bellorin-FontMohammed Benghanem GharbiSara N DavisonMohammad GhnaimatPaul HardenVivekanand JhaKamyar Kalantar-ZadehPeter KerrScott KlarenbachCsaba KovesdyValerie LuyckxBrendon NeuenDonal O'DonoghueShahrzad OssarehJeffrey PerlHarun Ur RashidEric RondeauEmily SeeSyed SaadLaura SolaIrma TchokhonelidzeVladimir TesarKriang TungsangaRumeyza Turan KazanciogluAngela Yee-Moon WangNatasha WiebeChih-Wei YangAlexander ZemchenkovMinhui ZhaoKitty J JagerFergus CaskeyVlado PerkovicKailash JindalIkechi G OkpechiMarcello TonelliJohn FeehallyDavid Ch HarrisDavid JohnsonPublished in: BMJ open (2021)
Significant gaps and variability exist in the public funding and oversight of ESKD care in many countries, particularly for those in low-income and lower-middle-income countries.